FDA wants pipeline failure data to be shared, but there is no discussion in Europe

FDA Commissioner Margaret Hamburg is pushing hard for more openness from the industry to release information to potential competitors on the reasons why drugs fail.

Speaking at the Financial Times Pharmaceutical and Biotechnology Conference held in London on 5 December 2011, the FDA Commissioner was talking about strategies within her 'Regulatory Science' initiative that could...